Filter
1506
Filtered Results: 1506
Text search:
drug
approval
Featured
Recommendations
105
New Publications
446
Language
Document type
No document type
913
Studies & Reports
253
Guidelines
186
Manuals
64
Strategic & Response Plan
35
Fact sheets
28
Training Material
15
Situation Updates
5
Resource Platforms
4
Infographics
2
Brochures
1
Countries / Regions
India
99
Kenya
47
Uganda
46
Global
42
Nigeria
39
South Africa
37
Malawi
35
Ethiopia
32
Nepal
32
Sierra Leone
30
Western and Central Europe
29
Myanmar / Burma
26
Liberia
25
Ukraine
25
Ghana
24
Bangladesh
24
Zambia
23
Tanzania
22
Rwanda
19
Latin America and the Carribbean
19
Namibia
17
Lesotho
17
Africa
15
Zimbabwe
14
South–East Asia Region
13
Eastern Europe
12
Botswana
11
Congo, Democratic Republic of
10
Burkina Faso
9
Senegal
8
Philippines
8
Cambodia
8
Asia
8
Syria
6
Thailand
6
Tajikistan
6
Russia
6
USA
5
Pakistan
5
Mozambique
5
Benin
5
Cameroon
4
South Sudan
4
Germany
4
China
4
Indonesia
4
Peru
4
East and Southern Africa
4
Venezuela
4
Albania
4
Afghanistan
3
Eswatini/ Swaziland
3
West and Central Africa
3
Eastern Europe and Central Asia
3
Georgia
3
Vietnam
3
Guinea
2
Somalia
2
Iraq
2
Central African Republic
2
Brazil
2
El Salvador
2
Mexico
2
Middle East and North Africa
2
Western Pacific Region
2
Bhutan
2
Laos
2
Moldova
2
Jamaica
2
Haiti
1
Lebanon
1
Turkey
1
Sudan
1
Argentina
1
Colombia
1
Libya
1
Madagascar
1
Sri Lanka
1
Chile
1
Yemen
1
Paraguay
1
Fiji
1
Palestine
1
Armenia
1
Southern Africa
1
Qatar
1
Iran
1
Uzbekistan
1
Kyrgyzstan
1
Australia
1
Kazakhstan
1
Turkmenistan
1
France
1
United Kingdom
1
Portugal
1
Spain
1
Belarus
1
Authors & Publishers
Publication Years
Category
Countries
662
Clinical Guidelines
127
Public Health
52
Women & Child Health
41
Pharmacy & Technologies
36
Key Resources
26
Capacity Building
12
Toolboxes
HIV
179
TB
142
AMR
111
COVID-19
82
Mental Health
79
Pharmacy
71
NTDs
42
Ebola
29
NCDs
28
Rapid Response
26
Caregiver
25
Planetary Health
17
Conflict
13
Global Health Education
13
Refugee
12
Health Financing Toolbox
12
Disability
11
Polio
6
Zika
6
Natural Hazards
5
Specific Hazards
4
Cholera
2
Social Ethics
1
To support its R&D activities on Chagas disease, DNDi launched the Chagas Clinical Research Platform (CCRP). The platform brings together partners, experts, and stakeholders to provide support for evaluation and development of new treatments for Chagas disease. The patient-centred platform aims to f...
This report provides an update on the key facets of HIV treatment access, including the latest HIV treatment guidelines from World Health Organization (WHO), an overview on pricing for first-line, second-line, and salvage regimens, and a summary of the opportunities for – and threats to – expand...
Global Tuberculosis Report 2022 Factsheet
recommended
The World Health Organization Global TB Report provides a comprehensive and up-to-date assessment of the TB epidemic, and progress in the response, at global, regional and country levels.
The 2022 edition features data on disease trends and the response to the epidemic from 215 countries and area...
The report provides a brief introduction to patents and licences and their effect on the market for antiretroviral (ARV) medicines. It gives an overview of the patent landscape with respect to a select number of ARV medicines in developing countries as of April 2014. The focus is primarily on those ...
Drugs and medical supplies are dispensed at the cutting edge level of the interface between the public health system and the people. Availability or lack of it brings either credit or discredit to the public health system. The primary reason for holding stocks of medicines and medical supplies in a ...
An Act to repeal the Dangerous Medicines Act of 1973,to ensure the availability of certain drugs for exclusive medical, scientific and related purposes, while preventing their abuse; to prevent the diversion from lawful trade of controlled chemicals, controlled equipment and controlled materials for...
Review of International, Regional and National Policies and Legal Frameworks that Promote Migrants and Mobile Populations' Access to Health and Malaria Services in the Greater Mekong Subregion (Cambodia, Lao People's Democratic Republic, Myanmar, Thailand and Viet Nam)
Migrants and mobile popul...
Migrants and mobile popul...
The guidelines are aimed at clinical professionals directly involved with and responsible for the care of adults with HIV infection, and at community advocates responsible for promoting the best interests and care of HIV-positive adults. They should be read in conjunction with other published BHIVA ...
Antibiotics have been a critical public health tool since the discovery of Penicillin in 1928, saving the lives of millions of people around the world. In developing country like ours, where the burden of treatable disease is very high and access to health facilities and laboratories is difficult, a...
Historically, the discovery of the sulfa drugs in the 1930s and the subsequent development of penicillin during World War II ushered in a new era in the treatment of infectious diseases. Infections that were common causes of death and disease in the pre-...
The Libyan national action plan has been aligned with WHO five objectives. Analysis of the current situation and addressing the gaps and the needs to reach the main goal “one health” approach involves several national sectors and actors, including human and veterinary health, agriculture and foo...
9 June 2021
Since its launch, GLASS has expanded in scope and coverage and as of May 2021, 109 countries and territories worldwide have enrolled in GLASS. A key new component in GLASS is the inclusion of antimicrobial consumption (AMC) surveillance at the national level highlighted in this fourth G...
Nat Commun 9, 5370 (2018). https://doi.org/10.1038/s41467-018-07804-8. Mycobacterium ulcerans is the causative agent of Buruli ulcer, a neglected tropical skin disease that is most commonly found in children from West and Central Africa. Despite the severity of the infection, therapeutic options are...
Since 1996, trachoma has been targeted for elimination as a public health problem worldwide. The active trachoma criterion for national elimination as a public health problem is a TF1–9 < 5%, sustained for at least two years in the absence of antibiotic mass ... administration (MDA), in each formerly endemic EU. Using A, F and E, health ministries and their partners have made considerable progress towards achieving this criterion in formerly endemic EUs worldwide. In 2002, an estimated 1517 million people lived in EUs in which EU-wide implementation of the A, F and E components of SAFE were thought to be needed for the purposes of global elimination of trachoma as a public health problem; by June 2021, that number had fallen to 136.2 million, a 91% reduction. Approximately 85% of the 136.2 million people living in EUs needing A, F and E in June 2021 were in WHO’s African Region.
The Practical manual on laboratory strengthening, 2022 update provides practical guidance on implementation of WHO recommendations and best practices for TB laboratory strengthening. It is an updated version of the GLI Practical Guide to Laboratory Strengthening published in 2017 and provides the la...
sthma prevalence is increasing worldwide, and surveys indicate that most patients in developed and developing countries, including South Africa, do not receive optimal care and are therefore not well controlled. Standard management guidelines adapted to in-country realities are important to support ...
The larval stage of the parasite Taenia solium can encyst in the central nervous system causing neurocysticercosis, which is the main cause of acquired epilepsy in the countries in which the parasite is endemic. Endemic areas are those with the presence (or likely presence) of the full life cycle of...
The sub-Saharan African region, carries 90% of the over 250 million cases of schistosomiasis occurring worldwide. In this region, after Nigeria, Tanzania is second country having the highest cases of schistosomiasis and approximately 51.5%0 of the Tanzanian population is either exposed or live in ar...
The manufacturing process is one of the key steps where quality control is required to ensure quality of medicinal products, including herbal medicines. Good manufacturing practices (GMP) is one of the most important tools for this measure.
